Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection - PubMed (original) (raw)
Novel, cross-restricted, conserved, and immunodominant cytotoxic T lymphocyte epitopes in slow progressors in HIV type 1 infection
P J Goulder et al. AIDS Res Hum Retroviruses. 1996.
Abstract
HIV-specific cytotoxic T lymphocytes (CTLs) play an important role in the immune response to HIV infection. Long-term nonprogressors (LTNPs) or slow progressors (SPs) in HIV infection may make qualitatively different CTL responses compared to those generated by seropositive individuals who progress to disease at a faster rate. The class I molecule HLA-B*57 has been identified as one restriction element overrepresented in SP groups studied, and, together with the closely related molecule HLA-B*58, occurs commonly in ethnic groups where HIV is most prevalent. In this study, we have identified five new HLA-B*57-restricted CTL epitopes recognized by SP donors, one of which is also HLA-B*5801 restricted. These HLA-B*57-restricted responses represent the dominant HIV-specific CTL response in each of the SP donors tested. These and other such epitopes may be an important component in future vaccine design.
Similar articles
- HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China.
Zhai S, Zhuang Y, Song Y, Li S, Huang D, Kang W, Li X, Liao Q, Liu Y, Zhao Z, Lu Y, Sun Y. Zhai S, et al. Curr HIV Res. 2008 Jun;6(4):335-50. doi: 10.2174/157016208785132473. Curr HIV Res. 2008. PMID: 18691032 - Clinical Control of HIV-1 by Cytotoxic T Cells Specific for Multiple Conserved Epitopes.
Murakoshi H, Akahoshi T, Koyanagi M, Chikata T, Naruto T, Maruyama R, Tamura Y, Ishizuka N, Gatanaga H, Oka S, Takiguchi M. Murakoshi H, et al. J Virol. 2015 May;89(10):5330-9. doi: 10.1128/JVI.00020-15. Epub 2015 Mar 4. J Virol. 2015. PMID: 25741000 Free PMC article. - Identification of highly conserved and broadly cross-reactive HIV type 1 cytotoxic T lymphocyte epitopes as candidate immunogens for inclusion in Mycobacterium bovis BCG-vectored HIV vaccines.
Ferrari G, Kostyu DD, Cox J, Dawson DV, Flores J, Weinhold KJ, Osmanov S. Ferrari G, et al. AIDS Res Hum Retroviruses. 2000 Sep 20;16(14):1433-43. doi: 10.1089/08892220050140982. AIDS Res Hum Retroviruses. 2000. PMID: 11018863 Review. - Efficient processing of the immunodominant, HLA-A*0201-restricted human immunodeficiency virus type 1 cytotoxic T-lymphocyte epitope despite multiple variations in the epitope flanking sequences.
Brander C, Yang OO, Jones NG, Lee Y, Goulder P, Johnson RP, Trocha A, Colbert D, Hay C, Buchbinder S, Bergmann CC, Zweerink HJ, Wolinsky S, Blattner WA, Kalams SA, Walker BD. Brander C, et al. J Virol. 1999 Dec;73(12):10191-8. doi: 10.1128/JVI.73.12.10191-10198.1999. J Virol. 1999. PMID: 10559335 Free PMC article. - Dynamic interplay between viral adaptation and immune recognition during HIV-1 infection.
Motozono C, Mwimanzi P, Ueno T. Motozono C, et al. Protein Cell. 2010 Jun;1(6):514-9. doi: 10.1007/s13238-010-0068-0. Epub 2010 Jul 7. Protein Cell. 2010. PMID: 21204005 Free PMC article. Review.
Cited by
- Polymorphic residues in HLA-B that mediate HIV control distinctly modulate peptide interactions with both TCR and KIR molecules.
Tano-Menka R, Singh NK, Muzhingi I, Li X, Mandanas MV, Kaseke C, Crain CR, Zhang A, Ogunshola FJ, Vecchiarello L, Piechocka-Trocha A, Bashirova A, Birnbaum ME, Carrington M, Walker BD, Gaiha GD. Tano-Menka R, et al. Structure. 2024 Aug 8;32(8):1121-1136.e5. doi: 10.1016/j.str.2024.04.015. Epub 2024 May 10. Structure. 2024. PMID: 38733995 Free PMC article. - Chimeric antigen receptors enable superior control of HIV replication by rapidly killing infected cells.
Zhou Y, Jadlowsky J, Baiduc C, Klattenhoff AW, Chen Z, Bennett AD, Pumphrey NJ, Jakobsen BK, Riley JL. Zhou Y, et al. PLoS Pathog. 2023 Dec 15;19(12):e1011853. doi: 10.1371/journal.ppat.1011853. eCollection 2023 Dec. PLoS Pathog. 2023. PMID: 38100526 Free PMC article. - Proviral location affects cognate peptide-induced virus production and immune recognition of HIV-1-infected T cell clones.
Dragoni F, Kwaa AK, Traut CC, Veenhuis RT, Woldemeskel BA, Camilo-Contreras A, Raymond HE, Dykema AG, Scully EP, Rosecrans AM, Smith KN, Bushman FD, Simonetti FR, Blankson JN. Dragoni F, et al. J Clin Invest. 2023 Nov 1;133(21):e171097. doi: 10.1172/JCI171097. J Clin Invest. 2023. PMID: 37698927 Free PMC article. - Features of functional and dysfunctional CD8+ T cells to guide HIV vaccine development.
Bhattacharyya S, Crain CR, Goldberg B, Gaiha GD. Bhattacharyya S, et al. Curr Opin HIV AIDS. 2023 Sep 1;18(5):257-263. doi: 10.1097/COH.0000000000000812. Epub 2023 Jul 18. Curr Opin HIV AIDS. 2023. PMID: 37535040 Free PMC article. Review. - Control of HIV-1 Replication by CD8+ T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.
Nguyen HT, Kuse N, Zhang Y, Murakoshi H, Maeda Y, Tamura Y, Maruyama R, Tran GV, Nguyen TV, Nguyen KV, Oka S, Chikata T, Takiguchi M. Nguyen HT, et al. J Virol. 2022 Oct 12;96(19):e0081122. doi: 10.1128/jvi.00811-22. Epub 2022 Sep 26. J Virol. 2022. PMID: 36154612 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials